Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Fynapse contract win with major existing client

1 Jul 2024 07:00

RNS Number : 4795U
Aptitude Software Group PLC
01 July 2024
Β 

1 July 2024

Aptitude Software Group plc

("Aptitude", "the Group")

Β 

Fynapse contract win with a major existing Aptitude Accounting Hub client

Β 

Aptitude (LSE: APTD), a market-leading provider of autonomous finance software solutions, is pleased to announce a Fynapse contract win with an existing Aptitude Accounting Hub client, a leading global insurer with operations in over 50 countries and territories (the "Client"). The Client has entered into a three-year expansion contract in excess of Β£4m incorporating Aptitude's next-generation Finance Data Management platform, Fynapse and the Aptitude Accounting Hub, adding to the Group's Annual Recurring Revenue ('ARR').

Β 

The three-year contract has commenced in June and will generate a Β£0.4m incremental uplift per annum to the existing total software contractual commitment, delivering a total software contract value for the three years in excess of Β£4.0m.

Β 

The Client wanted to move to autonomous finance and avoid a monolithic, lengthy and costly "big bang" implementation, opting instead for a rapid, incremental and flexible approach made possible by Fynapse due to its modular nature and speed of implementation.

Β 

With a substantial existing Aptitude Accounting Hub customer base, the opportunity for Fynapse expansion contracts is significant and a key strategic focus for the Group.

Β 

Alex Curran, CEO of Aptitude, said: "We are delighted to continue our work with this client, supporting their autonomous finance journey with our next-generation Fynapse platform. The selection by a leading global insurer underscores the demand for an alternative approach to finance transformation and showcases the platform's appeal to a top-tier financial services organization."

Β 

Aptitude Software Group plc

Β 

Ivan Martin, Chairman

020-3687-3200

Alex Curran, Chief Executive Officer

Mike Johns, Chief Financial Officer

Alma Strategic Communications

Β 

Caroline Forde / Hilary Buchanan / Will Ellis Hancock

020-3405-0205

Β 

About Aptitude Software

Β 

Aptitude Software provides software solutions that deliver fully autonomous finance to enable its clients to drive growth, efficiency and sustainability. Fynapse is Aptitude's intelligent finance data management and accounting platform designed to increase productivity and lower costs for finance teams globally.Β Fynapse provides a single view of finance and business data, unparalleled performance and automation, faster and better insights, user-friendly functionality and market-leading total cost of ownership.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
CNTFLFIARTIIVIS
Date   Source Headline
4th May 20218:55 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSAppointment of Joint Broker
27th Apr 202111:28 amRNSResult of AGM
27th Apr 20217:00 amRNSAGM Statement
9th Apr 202111:14 amRNSHolding(s) in Company
29th Mar 20212:06 pmRNSBlock listing Interim Review
23rd Mar 202111:13 amRNSDirector/PDMR Shareholding
11th Mar 20214:44 pmRNSBlock Listing Application
2nd Mar 20217:00 amRNSNotice of Results
1st Mar 202112:36 pmRNSTotal Voting Rights
19th Jan 20217:00 amRNSTrading Update
6th Jan 20214:23 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20209:13 amRNSHolding(s) in Company
1st Dec 202010:09 amRNSTotal Voting Rights
23rd Nov 20205:37 pmRNSHolding(s) in Company
28th Oct 20201:58 pmRNSDirector/PDMR Shareholding
29th Sep 20204:41 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
28th Sep 202010:48 amRNSBlock listing Interim Review
9th Sep 20204:24 pmRNSGrant of awards under Performance Share Plan
2nd Sep 20201:38 pmRNSDirector Declaration
11th Aug 202012:19 pmRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSInterim Results
6th Jul 20207:23 amRNSHolding(s) in Company
6th Jul 20207:21 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSTrading Update and Notice of Results
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSTotal Voting Rights
29th Apr 202012:16 pmRNSDisclosure of Rights attached to Ordinary Shares
28th Apr 202012:45 pmRNSResult of AGM
21st Apr 20207:00 amRNSCOVID-19 Update and AGM Arrangements
8th Apr 20205:02 pmRNSDirector/PDMR Shareholding
8th Apr 20204:59 pmRNSDirector/PDMR Shareholding
27th Mar 202012:38 pmRNSBlock listing Interim Review
18th Mar 20205:00 pmRNSAnnual Report and Notice of AGM
16th Mar 20201:52 pmRNSBlock Listing Application
13th Mar 20205:11 pmRNSDirector/PDMR Shareholding
11th Mar 20207:00 amRNSAudited Preliminary Results
13th Feb 20205:26 pmRNSHolding(s) in Company
3rd Feb 20201:54 pmRNSTotal Voting Rights
22nd Jan 20202:44 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSTrading Update, Board Changes & Notice of Results
15th Jan 202012:01 pmRNSHolding(s) in Company
3rd Jan 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jan 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.